# PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation

Study · id `cardio:ct-nct02463851` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02463851](<https://clinicaltrials.gov/study/NCT02463851>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02463851

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.

## Technical summary

Registry record NCT02463851. Randomized; no masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2021-04-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 212 participants (enrolled count; ClinicalTrials.gov record NCT02463851, source copy `cardio:ctgov-nct02463851-2021-09-23`, retrieved 2026-10-26)
- Start date: 2015-06 (registry gives no type) (ClinicalTrials.gov record NCT02463851, source copy `cardio:ctgov-nct02463851-2021-09-23`, retrieved 2026-10-26)
- Primary completion: 2021-04-01 (actual) (ClinicalTrials.gov record NCT02463851, source copy `cardio:ctgov-nct02463851-2021-09-23`, retrieved 2026-10-26)
- Completion: 2021-04-01 (actual) (ClinicalTrials.gov record NCT02463851, source copy `cardio:ctgov-nct02463851-2021-09-23`, retrieved 2026-10-26)
- Countries: Germany; Netherlands (ClinicalTrials.gov record NCT02463851, source copy `cardio:ctgov-nct02463851-2021-09-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02463851-2021-09-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation
- Acronym: GOLD-FORCE
- Condition: Atrial Fibrillation
- Intervention (Device): PVAC GOLD multielectrode catheter
- Intervention (Device): Contact Force single-tip ablation catheter
- Lead sponsor: L.V.A. Boersma
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 4d894d946d8f2ca00a10143d27d5f68c4cd5d6992e4f8e46a04b2a8ba92118de
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
